Pharmacokinetics of imidocarb dipropionate in horses after intramuscular administration

Equine Veterinary Journal

Volumn 34, Issue 6, 2002, Pages 625-629

  Belloli, C ^a   Crescenzo, G ^a   Lai, O ^a   Carofiglio, V ^a   Marang, O ^b   Ormas, P ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Veterinary practitioner   (Italy)

Author keywords

Horse; Imidocarb dipropionate; Pharmacokinetics; Piroplasmosis

Indexed keywords

IMIDOCARB DIPROPIONATE; ANTIPROTOZOAL AGENT; DRUG DERIVATIVE; IMIDOCARB;

ANIMAL EXPERIMENT; ARTICLE; BABESIA CABALLI; BABESIOSIS; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG SCREENING; FECES ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; ION EXCHANGE CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MILK; NONHUMAN; SOLID PHASE EXTRACTION; TISSUE DISTRIBUTION; URINALYSIS; ANIMAL; ANIMAL DISEASE; CHEMISTRY; FECES; FEMALE; HALF LIFE TIME; HORSE DISEASE; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY;

ANIMALIA; BABESIA; BABESIA CABALLI; EQUIDAE; EQUUS CABALLUS;

ANIMALS; ANTIPROTOZOAL AGENTS; BABESIOSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FECES; FEMALE; HALF-LIFE; HORSE DISEASES; HORSES; IMIDOCARB; INJECTIONS, INTRAMUSCULAR; MALE; METABOLIC CLEARANCE RATE; MILK; TISSUE DISTRIBUTION; URINALYSIS;

EID: 0036716122     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516402776180124     Document Type: Article

References (28)

1. Abdullah, A.S. and Baggot, J.D. (1983) Pharmacokinetics of imidocarb in normal dog and goats. J. vet. Pharmacol Ther 6, 195-199.
2. Aktas, M., Vinclair, P., Lefebvre, H.V., Toutain, P.L. and Braun, J.P. (1995) In vivo quantification of muscle damage in dogs after intramuscular administration of drugs. Br vet J. 151, 189-196
3. Ahu, Y.O., Davis, P.H , Camp, B.J and Kuttler, K.L (1977) Absorption, distribution and excretion of imidocarb dipropionate in sheep Am. J. vet. Res. 38, 2001-2007.
4. Anon (1998) Imidocarb Summary Report. Committee for Veterinary Medicinal Products (CVMP) EMEA/MRL/444/98 (www.emea eu int)
5. Beveridge, E (1969) Babesicidal effect of basically substituted carbanilides. Res vet. Sci. 10, 534-539.
6. Brasseur, P., Lecoublet, S., Kapel, N., Favennec, L and Ballet, J.J (1998) In vitro evaluation of drug susceptibilities ot Babesia divergens isolates. Antimicrob. Agents Chemother. 42, 818-820.
7. Brüning, A. (1996) Equine piroplasmosis: an update on diagnosis, treatment and prevention Br. vet J. 152, 139-151.
8. Coldham, N.G , Moore, A S , Sivapathasundaram, S. and Sauer, M J. (1994) Imidocarb depletion from cattle liver and mechanism of retention in isolated bovine hepatocytes. Analyst 9, 2549-2552.
9. Coldham, N G , Moore, A.S., Dave, M., Graham, P.J., Sivapathasundaram, S , Lake, B.G. and Sauer, M.J. (1995) Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity. Drug Metab. Disp. 23, 501-505.
10. de Waal, D.T. (1992) Equine piroplasmosis a review. Br. vet. J. 148, 6-14
11. Frenchs, W.M. and Holbrook, A A. (1974) Treatment of equine piroplasmosis (B caballi) with imidocarb dipropionate. Vet. Rec. 95, 188-189.
12. Frenchs, W.M , Allen, P.C. and Holbrook, A.A. (1973) Equine piroplasmosis (Babesia equi), therapeutic trials of imidocarb dihydrocloride in horses and donkeys. Vet. Rec. 93, 73-75.
13. Gummow, B., Du Preez, J.L. and Swan, G.E. (1995) Paired-ion extraction and high-performance liquid chromatographic determination of diminazene in cattle plasma a modified method Onderstepoort J. vet Res. 62, 1-5.
14. Knowles, R.C., Hourrigan, J.L. and Holbrook, A.A. (1980) Equine piroplasmosis. Equine Pract. 2, 10-14
15. Kuttler, K.L. (1980) Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis. J Am. vet. med Ass 176, 1103-1108.
16. Kuttler, K L., Zaugg, J.L. and Gipson, C A (1987) Imidocarb and parvaquone in the treatment of piroplasmosis (Babesia equi) in equids. Am. J vet. Res. 48, 1613-1617
17. Lam, F.C , Hurng, C T. and Perrier, D.G. (1985) Estimation of variance for harmonic mean half-lives J. Pharmacol. Sci. 74, 229-231.
18. McHardy, N., Woollon, R.M., Clampitt, R.B., James, J.A. and Crawley R.J. (1986) Efficacy, toxicity and metabolism of imidocarb dipropionate in the treatment of Babesia ovis infection in sheep. Res. vet. Sci. 41, 14-20.
19. Moore, A.S., Coldham, N.G and Sauer, M J. (1996) A cellular mechanism for imidocarb retention in edible bovine tissues. Toxicol. Lett. 87, 61-68.
20. Purnell, R.E., Lewis, D. and Young, E.R. (1980) Investigation on the prophylactic effect of treatment with imidocarb dipropionate on Babesia divergens infection in splenectomized calves. Br. vet J 136, 452-456.
21. Riegelman, S. and Collier, P. (1980) The application of the statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J. Pharmacokinet Biopharm. 8, 509-534
22. Rodriguez, R I and Trees, A.J. (1996) In vitro responsiveness of Babesia bovis to imidocarb dipropionate and selection of a drug-adapted line. Vet. Parasitol. 62, 35-41
23. Singh, B., Banerjee, D P and Gautam, O P. (1980) Comparative efficacy of diminazene diaceturate and imidocarb dipropionate against Babesia equi infection in donkeys. Vet Parasitol. 7, 173-179.
24. Soulé. C (1997) Le babesiosi equine Summa 3, 63-67
25. Tarbin, J.A and Shearer, G. (1992) High-performance liquid chromatographic determination of imidocarb in cattle kidney with cation-exchange clean-up J Chromatogr 577, 376-381
26. Timofeev, B.A., Bolotin, I M., Stepanova, L.P., Bogdanov, A A. Jr., Georgiu, Kh., Malyshev, S.N., Petrovsky, V.V., Klibanov, A.L. and Torchilin, V.P. (1994) Liposomal diamidine (imidocarb): preparation and animal studies J. Microencapsulation 11, 627-632.
27. Vercammen, F., De Deken, R. and Maes, L (1996) Prophylactic activity of imidocarb against experimental infection with Babesia canis. Vet. Parasitol 63, 195-198.
28. Yamaoka, K., Tanigawara, Y., Nakagawa, T. and Uno, T (1978) Application of Atkaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations J. Pharmacokinet. Biopharm 6, 165-175.